SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : biotech firesales -- Ignore unavailable to you. Want to Upgrade?


To: tuck who wrote (2931)6/23/2012 4:36:17 PM
From: DewDiligence_on_SI  Read Replies (1) | Respond to of 3661
 
> I might add this fall, as I feel that eventually MNTA will get FDA approval for generic Copaxone. Indeed, some were interpreting MNTA's recent strength as anticipation of imminent approval.

No one knows when the FDA will approve the Copaxone ANDA, but nothing changed on this score this weekend. I.e. the FDA’s decision on the ANDA is independent of the ruling in the patent case.